Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera.
Animals
Antibodies, Bacterial
/ blood
Bacterial Proteins
/ immunology
Convalescence
Enzyme-Linked Immunosorbent Assay
/ methods
Immunoglobulin G
/ blood
Mycoplasma hyopneumoniae
/ immunology
Pneumonia of Swine, Mycoplasmal
/ blood
Recombinant Proteins
/ immunology
Reproducibility of Results
Sensitivity and Specificity
Swine
Swine Diseases
/ blood
Convalescent sera
IgG
Indirect ELISA
Mhp366
Mycoplasma hyopneumoniae
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
16 Mar 2021
16 Mar 2021
Historique:
received:
12
11
2020
accepted:
03
03
2021
entrez:
17
3
2021
pubmed:
18
3
2021
medline:
17
8
2021
Statut:
epublish
Résumé
Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti-M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti-M. hyopneumoniae IgG in inactivated bacterin-induced hyperimmune sera and convalescent sera resulting from natural M. hyopneumoniae infection. Establishment of an ELISA to detect anti-M. hyopneumoniae IgG in convalescent sera will facilitate the evaluation of the M. hyopneumoniae status of pig farms. In this study, we expressed and purified recombinant Mhp366-N protein, which contains an epitope recognized by M. hyopneumoniae convalescent sera but not hyperimmune sera, for use as a coating antigen. For the M. hyopneumoniae convalescent serum IgG-ELISA, the optimal antigen concentration, blocking buffer, blocking time, dilution of serum, incubation time with serum, secondary antibody dilution, secondary antibody incubation time and colorimetric reaction time were 0.25 µg/mL, 2.5 % skim milk, 1 h, 1:500, 0.5 h, 1:10,000, 1 h and 15 min, respectively. Validation of the M. hyopneumoniae convalescent serum IgG-ELISA showed a cut-off value of 0.323, the intra-assay CV ranged from 3.27 to 7.26 %, the inter-assay CV ranged from 3.46 to 5.93 %, and the assay was able to differentiate convalescent sera from antibodies to 7 other porcine respiratory pathogens. The convalescent serum IgG-ELISA detected no anti-M. hyopneumoniae IgG in hyperimmune serum samples while a commercial IgG-ELISA identified 95/145 of these sera as positive. The accuracy of the M. hyopneumoniae convalescent serum IgG-ELISA was comparable to the sIgA-ELISA but better than the commercial IgG-ELISA. The convalescent serum IgG-ELISA is a reproducible, sensitive, and specific indirect ELISA to detect anti-M. hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera. This ELISA could be used to carry out large scale surveillance of M. hyopneumoniae infection in pig farms regardless of vaccination status.
Sections du résumé
BACKGROUND
BACKGROUND
Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti-M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti-M. hyopneumoniae IgG in inactivated bacterin-induced hyperimmune sera and convalescent sera resulting from natural M. hyopneumoniae infection. Establishment of an ELISA to detect anti-M. hyopneumoniae IgG in convalescent sera will facilitate the evaluation of the M. hyopneumoniae status of pig farms.
RESULTS
RESULTS
In this study, we expressed and purified recombinant Mhp366-N protein, which contains an epitope recognized by M. hyopneumoniae convalescent sera but not hyperimmune sera, for use as a coating antigen. For the M. hyopneumoniae convalescent serum IgG-ELISA, the optimal antigen concentration, blocking buffer, blocking time, dilution of serum, incubation time with serum, secondary antibody dilution, secondary antibody incubation time and colorimetric reaction time were 0.25 µg/mL, 2.5 % skim milk, 1 h, 1:500, 0.5 h, 1:10,000, 1 h and 15 min, respectively. Validation of the M. hyopneumoniae convalescent serum IgG-ELISA showed a cut-off value of 0.323, the intra-assay CV ranged from 3.27 to 7.26 %, the inter-assay CV ranged from 3.46 to 5.93 %, and the assay was able to differentiate convalescent sera from antibodies to 7 other porcine respiratory pathogens. The convalescent serum IgG-ELISA detected no anti-M. hyopneumoniae IgG in hyperimmune serum samples while a commercial IgG-ELISA identified 95/145 of these sera as positive. The accuracy of the M. hyopneumoniae convalescent serum IgG-ELISA was comparable to the sIgA-ELISA but better than the commercial IgG-ELISA.
CONCLUSIONS
CONCLUSIONS
The convalescent serum IgG-ELISA is a reproducible, sensitive, and specific indirect ELISA to detect anti-M. hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera. This ELISA could be used to carry out large scale surveillance of M. hyopneumoniae infection in pig farms regardless of vaccination status.
Identifiants
pubmed: 33726780
doi: 10.1186/s12917-021-02828-7
pii: 10.1186/s12917-021-02828-7
pmc: PMC7968261
doi:
Substances chimiques
Antibodies, Bacterial
0
Bacterial Proteins
0
Immunoglobulin G
0
Recombinant Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
123Subventions
Organisme : Fundamental Research Funds for the Central Universities
ID : XDJK2020B012
Organisme : Chongqing Technology Innovation and Application Development Project
ID : cstc2019jscx-msxmX0402
Références
Vet J. 2016 Jun;212:1-6
pubmed: 27256017
Vet Rec. 2020 Jan 4;186(1):27
pubmed: 31732508
Vet J. 2014 Oct;202(1):128-33
pubmed: 25066030
J Vet Diagn Invest. 2012 Mar;24(2):383-7
pubmed: 22379055
Vet Microbiol. 2010 Jul 14;143(2-4):238-45
pubmed: 20036079
Vet Microbiol. 2018 Sep;223:86-92
pubmed: 30173757
Vet Microbiol. 2018 Jun;219:23-29
pubmed: 29778201
Transbound Emerg Dis. 2018 May;65 Suppl 1:110-124
pubmed: 28834294
Vet Microbiol. 2010 Jul 14;143(2-4):410-6
pubmed: 20053508
Porcine Health Manag. 2018 Jun 1;4:12
pubmed: 29881637
Vet Microbiol. 2020 Feb;241:108500
pubmed: 31767388
Porcine Health Manag. 2018 Aug 1;4:19
pubmed: 30083374
Heliyon. 2020 Aug 31;6(8):e04832
pubmed: 32923730
J Vet Diagn Invest. 2015 Sep;27(5):606-10
pubmed: 26179099
Vet Microbiol. 2017 May;203:103-109
pubmed: 28619131
Vet Microbiol. 2009 Mar 2;134(3-4):261-6
pubmed: 18835112
J Microbiol Methods. 2017 Mar;134:30-34
pubmed: 28088341
BMC Vet Res. 2019 Sep 12;15(1):327
pubmed: 31511007
Vet J. 2009 Sep;181(3):221-31
pubmed: 18396428
Vet Microbiol. 2010 May 19;142(3-4):293-302
pubmed: 19913364
Sheng Wu Gong Cheng Xue Bao. 2018 Jan 25;34(1):44-53
pubmed: 29380570
J Appl Microbiol. 2018 Aug;125(2):345-355
pubmed: 29603531
Vet Microbiol. 2016 Nov 15;195:158-164
pubmed: 27771062
J Microbiol Methods. 2017 Nov;142:10-14
pubmed: 28844720
J Appl Microbiol. 2010 May;108(5):1523-33
pubmed: 19811567